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The pancreas is derived from a pool of multipotent progenitor cells (MPCs) that co-express Pdx-1 and Ptf1a. To more precisely define how the
individual and combined loss of Pdx-1 and Ptf1a affects pancreatic MPC specification and differentiation we derived and studied mice bearing a
novel Ptf1aYFP allele. While the expression of Pdx-1 and Ptf1a in pancreatic MPCs coincides between E9.5 and 12.5 the developmental
phenotypes of Pdx-1 null and Pdx-1; Ptf1a double null mice are indistinguishable, and an early pancreatic bud is formed in both cases. This
finding indicates that Pdx-1 is required in the foregut endoderm prior to Ptf1a for pancreatic MPC specification. We also found that Ptf1a is
neither required for specification of Ngn3-positive endocrine progenitors nor differentiation of mature β-cells. In the absence of Pdx-1 Ngn3-
positive cells were not observed after E9.5. Thus, in contrast to the deletion of Ptf1a, the loss of Pdx-1 precludes the sustained Ngn3-based
derivation of endocrine progenitors from pancreatic MPCs. Taken together, these studies indicate that Pdx-1 and Ptf1a have distinct but
interdependent functions during pancreatic MPC specification.
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The mouse pancreas originates as two evaginations of the
foregut endoderm at approximately embryonic day 9 (E9) (Guz
et al., 1995; Jonsson et al., 1994; Offield et al., 1996). Both the
dorsal and ventral pancreatic buds contain multipotent progeni-
tor cells (MPCs) that give rise to the endocrine, exocrine, and
ductal lineages of the pancreas (Gu et al., 2002; Kawaguchi et
al., 2002; Zhou et al., 2007). Recent studies suggest that a pool
of pancreatic MPCs is maintained until approximately E12.5
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doi:10.1016/j.ydbio.2008.01.011allocation of these MPCs into transit amplifying progenitor cell
subpopulations that have lineage-specific fates are not under-
stood. In this study we explored the roles of both pancreatic
and duodenal homeobox factor 1 (Pdx-1) and pancreas specific
transcription factor-1a (Ptf1a/p48) in controlling acquisition of
the MPC fate and how the loss of these factors affects
partitioning of these cells into the pro-endocrine cell compart-
ment as well as other non-pancreatic tissues.
Pdx-1 and Ptf1a/p48 (hereafter termed Ptf1a) have each
been previously shown to play vital roles in the growth and
lineage specification of pancreatic MPCs during development
(Chiang and Melton, 2003; Jonsson et al., 1994; Kawaguchi et
al., 2002; Krapp et al., 1998; Offield et al., 1996; Sellick et al.,
2004; Stoffers et al., 1997). The overlapping expression domain
of these transcription factors is thought to define the primordial
pancreatic endoderm (Chiang and Melton, 2003; Kawaguchi et
al., 2002). Pdx-1, which is first expressed at E8.5 in the
prospective posterior foregut, demarcates both pancreatic buds
by E9.5 as well as the endodermal region that produces the
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gall bladder, and cystic duct (Guz et al., 1995; Jonsson et al.,
1994; Offield et al., 1996). In contrast, Ptf1a, which is first
expressed in the pancreas at E9.5 (Chiang and Melton, 2003;
Kawaguchi et al., 2002; Krapp et al., 1998; Obata et al., 2001),
is additionally expressed in the neuronal precursors of the
cerebellum, spinal cord, and retina where it also performs fate
determining roles (Fujitani et al., 2006b; Glasgow et al., 2005;
Hoshino et al., 2005).
The developmental phenotypes of Pdx-1 and Ptf1a null mice
are similar in that both fail to form acinar cells, and thus lack a
normal pancreas (Jonsson et al., 1994; Krapp et al., 1998;
Offield et al., 1996). However, the defects that occur in Pdx-1
null mice are more widespread and include abnormalities in the
gastro-duodenal junction, submucosal Brunner's glands, enter-
oendocrine cell numbers in the stomach and duodenum, and
formation of peribiliary glands and mucin-producing cells in the
gall bladder (Fukuda et al., 2006b; Jonsson et al., 1994; Offield
et al., 1996). Moreover, Pdx-1 null animals, in contrast with
Ptf1a null mice, form only a small number of short-lived insulin-
producing cells as well as glucagon-producing cell clusters
(Ahlgren et al., 1996; Guz et al., 1995; Offield et al., 1996). In
Ptf1a mutants all islet endocrine cell types persist to late
embryogenesis (Kawaguchi et al., 2002; Krapp et al., 1998).
The commitment of pancreatic MPCs to the endocrine
lineage requires the expression of Neurogenin 3 (Ngn3)
(Gradwohl et al., 2000; Gu et al., 2002). Ngn3-positive cells
are normally detected around E9 within the pre-pancreatic
endoderm and are believed to give rise to both insulin- and
glucagon-expressing cells between approximately E9 and E12
(Apelqvist et al., 1999; Gradwohl et al., 2000). These early, so-
called first wave, endocrine cells do not appear to populate
mature islets (Herrera, 2000; Herrera et al., 1998). However,
beginning around E13.5, a second wave of endocrine cell
differentiation occurs during which five mono-hormone-
expressing cell types are specified: β-cells (insulin), α-cells
(glucagon), δ-cells (somatostatin), ε-cells (ghrelin), and PP
(pancreatic polypeptide) cells (Jensen, 2004; Murtaugh and
Melton, 2003; Wilson et al., 2003). The finding that the early
endocrine cell lineage is still specified in both Pdx-1 and Ptf1a
null mice suggests that neither factor is required for the
expression of Ngn3 (Ahlgren et al., 1996; Jonsson et al., 1994;
Kawaguchi et al., 2002; Krapp et al., 1998; Offield et al., 1996).
While Pdx-1 and Ptf1a clearly play vital functions in
pancreatic MPCs, little is known about how each of these genes
may influence each other, contribute to the maintenance of
pancreatic MPCs, or are involved in fate decisions that regulate
the segregation of these MPCs into specific pancreatic lineages.
Given the more restricted expression of Ptf1a in the broader
Pdx-1-positive foregut endoderm and its role in the specifica-
tion of pancreatic MPCs, it has been hypothesized that the
concurrent expression of Ptf1a and Pdx-1 elicits a commitment
towards pancreatic fates instead of other foregut organs
(Kawaguchi et al., 2002). Consistent with this idea, it has
been reported that pan-endodermal expression of XPtf1a in
Xenopus promotes ectopic pancreas formation only in sites
where Pdx-1 is expressed (Afelik et al., 2006). Furthermore, inHes1 null mice ectopic expression of Ptf1a in the CBD
promotes pancreas formation (Fukuda et al., 2006a).
The findings we report here provide new insights into the
interdependent roles of both Pdx-1 and Ptf1a in maintaining a
pool of pancreatic MPCs. These studies were facilitated by the
derivation of mice that express Yellow Fluorescent Protein
(YFP) in place of Ptf1a using a strategy that involved Recom-
binase Mediated Cassette Exchange (RMCE) (Feng et al.,
1999; Long et al., 2004). Utilizing the Ptf1aYFP allele in
combination with a Pdx-1 null allele, we analyzed how the
individual and combined loss of Pdx-1 and Ptf1a affects the
specification and differentiation of pancreatic MPCs as well as
the formation and maturation of endocrine cells.
Materials and methods
Gene targeting and RMCE
The Ptf1aLCA targeting vector contained homology arms of 5162 (ClaI to
SalI) and 2624 bp (SalI–PvuII) from a RPCI-22 BAC (clone 251-E16)
(Osoegawa et al., 2000). The two homology arms flank, consecutively, a loxP
site, a phosphoglycerol kinase (pgk)-driven neomycin resistance gene (neoR), a
pgk-driven Herpes Simplex Virus thymidine kinase gene (tk), and a second loxP
site whose orientation is inverted relative to the first site. In addition, a
Diphtheria toxin A expression cassette was located outside of the short arm. The
targeting vector was linearized with SacII prior to electroporation into TL-1
mouse ES cells.
The Ptf1aYFP(+HygroR) cassette exchange vector was made by inserting a
4105 bp fragment of the Ptf1a gene into a plasmid containing two inversely-
oriented LoxP sites, then changing a NotI site in the 5′ UTR to an FseI site.
DNA encoding Citrine (Heikal et al., 2000), an enhanced yellow fluorescent
protein (YFP) variant (obtained from David W. Piston; Vanderbilt) was then
inserted between the new FseI and a naturally-occurring MluI site in exon 1 of
the Ptf1a gene. A pgk-driven hygromycin resistance gene (HygroR), flanked by
tandem FRT sites, was inserted into a NotI site at the 3′ end of the exchange
vector for positive selection during RMCE.
Gene targeting was performed using standard protocols. Homologous
recombination was verified by Southern blot analysis after XmnI or EcoRI
digestion. RMCE was performed as previously described (Long et al., 2004).
Briefly, clone 5D12, which contains the Ptf1aLCA, was electroporated with both
the Ptf1aYFP(+HygroR) exchange vector and pBS185, a Cre-expression vector.
Clones surviving both hygromycin and gancyclovir were screened by PCR on
both the 5′ and 3′ ends using primers: 1:5′-CCTTCTGACTTCTCCAAGAA-
GGCA-3′, 2:5′-CCCTTTATGCCTGGCATTTCACTG-3′, 3: 5′-TTGACTCC-
CCAGGCTTGGACTGTT-3′, 4: 5′-ACCGATGGCTGTGTAGAAGTACT-3′,
5: 5′-TCTATCGCCTTCTTGACGAGTTCT-3′.
Mouse strains and husbandry
Chimeric mice were generated by microinjection of clone 5D12:1D3 ES
cells into blastocysts obtained from natural matings of C57BL/6J mice then bred
with other C57BL/6J mice to produce mice bearing the Ptf1aYFP(+HygroR) allele.
Removal of the FRT-flanked HygroR cassette was accomplished by inbreeding
with ACTB:FLPe mice (kindly provided by S.M. Dymecki, Harvard Medical
School, Boston, MA). The resulting allele, Ptf1aYFP, was maintained on an
outbred background. MIP:GFP transgenic mice were kindly provided by G.I.
Bell (U. Chicago). Mice containing the Pdx-1LacZ ko allele have been previously
described (Offield et al., 1996). All mice were maintained in a specific pathogen
free state with a 12 h light–dark cycle. Experimental protocols were approved by
the Vanderbilt Institutional Animal Care and Use Committee.
X-gal staining and immunodetection
For X-gal staining whole embryos or dissected gut tissues were fixed in 4%
paraformaldehyde in PBS at 4 °C for 30 min then washed with PBS twice
Fig. 1. Creation of a Ptf1aLCA allele and insertion of YFP by RMCE. (A)
Schematic representation of the Ptf1a locus, targeting vector, Ptf1aLCA allele,
Ptf1a-YFP exchange cassette, and the Ptf1aYFP(+HygroR) allele. A 4.1 kb Ptf1a
fragment including both exons was replaced by two pgk-driven selection
cassettes, neoR and HSV-tk, flanked by inversely orientated loxP sites during
gene targeting. A pgk-driven Diphtheria toxin A cassette is located beyond the
end of the short arm of DNA homology. YFP coding sequences replace 5′ UTR
andPtf1a coding sequences in exon 1. Exon 2 is retained in the exchange cassette
to supply RNA splicing and poly adenylation signals with a FRT-flanked
hygromycin resistance cassette located downstream of Ptf1a sequences for
positive selection following RMCE. Insertion of the YFP exchange cassette into
the Ptf1aLCA was accomplished by RMCE creating the Ptf1aYFP(+HygroR) allele
from which mice were derived. Restriction Endonucleases: ClaI (Cl), EcoRI (E),
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sodium deoxycholate, and 0.02% Nonidet P-40 in PBS). Fixed embryos or
dissected gut tissues were incubated overnight at RT with 1.0 mg/mL X-gal in
rinse buffer. Samples were post-fixed overnight in 4% paraformaldehyde/PBS at
4 °C. Whole embryos were rinsed twice in PBS then dehydrated in methanol. A
2:1 solution of benzyl benzoate: benzyl alcohol (Sigma-Aldrich) was used to
clear the dehydrated embryos. Dissected gut tissues were stored in 70% ethanol
after fixation.
For routine immunodetection, embryos and dissected tissues were fixed
overnight in 4% paraformaldehyde in PBS at 4 °C. Tissues were transferred to
30% sucrose in PBS and equilibrated at 4 °C (few hours to O/N). Embryos or
tissues were embedded in O.C.T. and frozen on dry ice. 10 μm frozen sections
were permeabilized with 0.2% Triton X-100 in PBS for 20 min, then washed 3
times in 0.1% Triton X-100 in PBS and 3 times in PBS alone. Sections were
preincubated with 5% normal donkey serum and 1% BSA in PBS for at least 1 h
at room temperature before applying primary antibody. Primary antibodies were
diluted in 1% BSA in PBS as follows: rabbit anti-GFP (Molecular Probes),
1:500; chicken anti-GFP (ABCAM), 1:500; guinea pig anti-Pdx-1 (Christopher
Wright), 1:1000; goat-anti Pdx-1 (Christopher Wright), 1:5000; guinea pig anti-
insulin (Linco), 1:1000; rabbit anti-glucagon (Linco), 1:1000; rabbit anti-Ptf1a
(Helena Edlund, Umeå U.), 1:500; guinea pig anti-Ngn3 (Maike Sander, U.C.
Irvine), 1:500; rabbit anti-MafA (Bethyl Laboratories), 1:1000. The anti-Pdx-1
antibodies recognize both Pdx-1 and the LacZ–Pdx-1 fusion protein expressed
from the Pdx-1LacZko allele. Tissue sections were incubated with primary
antibodies overnight at 4 °C then washed three times in PBS+0.1% Triton X-
100 and 3 times in PBS alone. Secondary antibodies were diluted in 1% BSA in
PBS as follows: donkey anti-rabbit IgG conjugated to Cy3 (Jackson Immuno
Research), 1:1000; donkey anti-rabbit IgG conjugated to Cy2 (Jackson Immuno
Research), 1:500; donkey anti-guinea pig IgG conjugated to Cy3 (Jackson
Immuno Research), 1:1000; donkey anti-guinea pig IgG conjugated to Cy2
(Jackson Immuno Research), 1:500; donkey anti-chicken conjugated to Cy2
(Jackson Immuno Research), 1:500; donkey anti-chicken conjugated to Cy3
(Jackson Immuno Research), 1:1000; donkey anti-goat conjugated to Alexa
Fluor 647 (Invitrogen), 1:500. Sections were incubated with secondary anti-
bodies for 1–3 h at room temperature and then washed three times in PBS+
0.1% Triton X-100 and 3 times in PBS alone. DRAQ5™ (Alexis) was diluted
1:1000 in PBS and used as a nuclear counterstain where noted. Cover slips were
mounted using Aqua/Poly Mount (Polysciences, Inc.). Bright field and
fluorescence images were acquired using either an Axioplan2 microscope
(Zeiss) equipped with a QImaging RETIGA EXi camera or a Leica MZ 16 FA
stereoscope with a QImaging RETIGA 4000R camera. Confocal microscopy
was performed using a Zeiss LSM 510.
Statistical analysis
The entire foregut, including the stomach, spleen, pancreas, and duodenum,
at E18.5 was dissected in order to determine the percentage of MafA positive
insulin-expressing cells in wild type and Ptf1a null embryos (n=3 for each
genotype). Confocal microscopy (1 μm optical slice) was performed on sections
immunostained for MafA and insulin. DRAQ5™ was used to stain nuclei. The
percentage of MafA positive, insulin-expressing cells was measured by counting
cells (based on presence of a nucleus) in at least 20 random fields of view per
embryo. Statistical significance was determined using a Student's two tail t test.PvuII (Pv), SalI (S), XmnI (Xm). (B) Southern blot analysis of ES cell genomic
DNA, using probes indicated in panel A, confirmed 3 ES cell clones that were
correctly targeted for the Ptf1aLCA allele, 2F12, 5B8, and 5D12. Clone 5D12 was
chosen for the RMCE experiment. (C) PCR screening of Ptf1aYFP(+HygroR)
cassette exchanged clones using primer pair combinations that detect cassettes in
the forward or reverse orientation on both the 5′ and 3′ ends. Clones 5D12:1C1
and 5D12:1D3 both contain the Ptf1aYFP(+HygroR) cassette in the forward
orientation. Primer locations are indicated in panel A and combinations are
indicated in panel C below their respective lanes.Results
Generation of a Ptf1aLCA allele in mouse ES cells and insertion
of YFP by RMCE
A three-step procedure was used to derive mice carrying the
Ptf1aYFP allele (Fig. 1). First, gene targeting replaced a 4.1 kb
region of the Ptf1a gene with two inversely-oriented loxP sites
flanking both neomycin resistance (neoR) and HSV-thymidine
kinase (HSV-tk) cassettes (Fig. 1A) to create a Ptf1a Loxed
Cassette Acceptor (Ptf1aLCA) allele. Three of the 244 ES cellclones screened were correctly targeted as indicated by
Southern blot analysis (Fig. 1B). Second, an exchange vector
was designed to replace Ptf1a coding sequences with those of
YFP while also replacing all but 613 bp of Ptf1a genomic
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was performed by co-electroporating the exchange vector with a
Cre-expression plasmid into Ptf1aLCA ES cells. Analysis of 9
clones that survived a staggered positive–negative selection
strategy (Long et al., 2004) revealed that all had undergone
exchange. Clone 5D12:1D3, in which the exchange event was
correctly orientated (Fig. 1C), was used to generate mice. Third,
mice containing the Ptf1aYFP(+HygroR) allele were interbred with
mice bearing a FLPe-expressing transgene to remove the FRT-
flanked HygroR cassette.
Ptf1aYFP expression by whole mount fluorescence microscopy
Expression of YFP from the Ptf1aYFP allele was first
assessed by whole mount fluorescence microscopy. In Ptf1a-
embryos YFP fluorescence was first seen at E10.5 in the
neural tube and the developing cerebellum (Fig. 2); sites of
bona fide Ptf1a expression (Glasgow et al., 2005; Hoshino et
al., 2005; Kawaguchi et al., 2002; Obata et al., 2001).
Pancreas-specific fluorescence was observed in the dorsal and
ventral pancreatic buds after dissecting the primordial gut tube
away from the rest of the embryo (Fig. 2). Transcription of the
Ptf1a gene is estimated to be considerably less than that of
Pdx-1 at this stage of development given that fluorescence
from a Pdx-1GFP allele is visible without the need to dissect
out the gut tissue (Holland et al., 2006). In E11.5 embryos,
Ptf1a-YFP fluorescence intensified (Fig. 2) with expression
occurring throughout the pancreatic epithelium upon fusion of
the dorsal and ventral pancreas at E12.5. By E13.5 pancreatic
fluorescence appeared as many clusters, consistent with the
expected restriction of Ptf1a expression to pro-acinar
structures at this stage of development. The fluorescence
intensity increased further by E15.5, corresponding with the
expansion of pancreatic exocrine cells (Fig. 2). In the adult,
pancreas-wide fluorescence was similar to that observed in
late embryogenesis (data not shown).
Ptf1aYFP expression by immunohistochemistry
To more precisely identify cells expressing YFP from the
Ptf1aYFP allele we next performed immunostaining experi-
ments. From E9.5–11.5, Ptf1a was detected throughout the
dorsal and ventral pancreatic buds, and YFP is exactly
coincident with that of Ptf1a (Fig. S1). To our knowledge,
this is the first report demonstrating Ptf1a protein in the pre-
pancreatic endoderm at E9.5. At E12.5, when Ptf1a is expressed
in MPCs residing in the distal tips of the branching epithelium at
the periphery of the pancreas tissue, intense YFP immuno-
fluorescence co-localized with Ptf1a except for some weaker,
residual YFP staining towards the central part of the pancreas
epithelium (Fig. S1). This is probably due to YFP having a
modestly longer half-life than Ptf1a. Therefore, the perdurance
of YFP transiently lineage labels cells that have recently ceased
Ptf1a transcription and provides further evidence that MPCs in
the distal epithelial tips give rise to the Ptf1a-negative cells
found in the core, or trunk region of the pancreas tissue (Zhou et
al., 2007). However, from E13.5 on, Ptf1a and YFP wereentirely coincident in all acinar cells, consistent with upregula-
tion of Ptf1a and the appearance of exocrine enzymes such as
amylase at this stage of development (Chiang and Melton,
2003; Guz et al., 1995). Moreover, YFP was detected in all non-
pancreatic expression domains of Ptf1a and therefore indicates
Ptf1aYFP expression faithfully recapitulates that of the wild type
allele (data not shown).
Ptf1a expressing progenitors are depleted by ∼E13.5 in Ptf1a
null embryos
Previously, lineage tracing experiments demonstrated label-
ing of a MPC population in the posterior foregut of Ptf1aCre/Cre
mice at E10.5 (Kawaguchi et al., 2002). However, those
experiments did not ascertain the duration of Ptf1a gene
expression. Therefore, having shown that YFP reliably reports
Ptf1a transcription, we sought to determine the spatiotemporal
expression pattern of Ptf1a past E10.5 in Ptf1aYFP/YFP embryos.
YFP expression was observed by whole mount fluorescent
microscopy in both the dorsal and ventral pancreatic buds at
E10.5 (Fig. 2). Similarly, at E11.5 YFP was seen in both the
dorsal and ventral buds although expression in the ventral
pancreatic remnant (VPR) disappears by E12.5 (Fig. 2).
However, in contrast to the VPR, Ptf1aYFP expression in the
DPR persists until E13.5, but then is no longer seen at E15.5 in
the absence of Ptf1a (Fig. 2). The persistence of YFP
fluorescence in the pancreatic remnants suggests that the
foregut endodermal cells remain multipotent, and/or that they
continue to respond to cell-autonomous and/or non-autonomous
Ptf1a-inducing signals through mid-gestation. The loss of YFP
fluorescence appears to be due to the dorsal Ptf1a null cells
being specified to limited pancreatic fates and to the ventral
Ptf1a null cells being reassigned to duodenal cell types
(Kawaguchi et al., 2002; Krapp et al., 1998). This indicates
that there is a limited time window, extending from ∼E10.5–
13.5, for the pancreatic MPCs to respond to the pro-pancreatic
function of Ptf1a or to other signals that may be necessary for
Ptf1a expression.
Ventral Ptf1a-deficient cells convert to a CBD fate
To determine how the loss of Ptf1a affects Pdx-1 expression
and pancreas morphogenesis, we next crossed mice bearing
the Ptf1aYFP allele with Pdx-1LacZko/+ animals to obtain both
Pdx-1LacZko/+; Ptf1aYFP/YFP and Pdx-1LacZko/+; Ptf1aYFP/+
embryos. Use of the Pdx-1LacZko allele is convenient in this
setting because it allows for high resolution imaging via X-gal
histochemistry of all foregut structures in wild type and mutant
embryos. Double heterozygous E12.5 embryos displayed
normal fusion of the dorsal and ventral pancreatic buds (Fig.
3A). The dorsal bud is normally connected to the duodenum
while the ventral bud stems from the common bile duct
(CBD), which itself extends from the duodenal ampulla to the
liver and gall bladder. However, in Ptf1a null embryos at
E12.5, fusion of the dorsal and ventral lobes did not occur and
growth of the DPR was diminished with the ventral pancreatic
remnant (VPR) appearing as a minute evagination of the CBD
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common embryonic origin as the CBD progenitors in Hes1
null mutants develop into pancreatic tissue (Fukuda et al.,
2006a; Sumazaki et al., 2004). Therefore we have hypothe-
sized that in the absence of Ptf1a, ventral pancreatic MPCs
contribute to CBD development. Ventral YFP fluorescence is
absent in Ptf1aYFP/YFP mice at E12.5 (Fig. 2) which precludes
immunofluorescence analysis of expression on sections, but at
E11.5 YFP expressing cells of the VPR are detected in a Pdx-
1-positive epithelial structure resembling the primordial CBD
or duodenum. While our analysis does not preclude the
possibility that some Ptf1a-derived cells may have already
contributed to the duodenum or CBD and ceased Ptf1a
transcription by E11.5, ventral Ptf1a null cells that continue to
express Ptf1aYFP did not appear to coalesce into a distinct
epithelial bud (Fig. 5D, third panel). This finding, when
considered with the results of previous studies, suggests that
ventral pancreatic MPCs are converted to duodenal and/or
CBD progenitor cells in the absence of Ptf1a (Kawaguchi et
al., 2002). In contrast, Ptf1a null dorsal pancreatic MPCs
organize into a distinct epithelial bud (Fig. 5D).
In E15.5 embryos that are null for Ptf1a (Pdx-1LacZko/+;
Ptf1aYFP/YFP) the DPR was seen to have undergone some
outgrowth from the duodenum towards the spleen, although it
was noticeably smaller and less branched when compared to
double heterozygous controls (compare Figs. 3B and D).
Furthermore, a VPR could not be discerned. Thus, we
hypothesized that these cells had become integrated into the
CBD epithelium and/or duodenum (Fig. 3D). For this reason we
further examined gut tissue from day E18.5 embryos that were
previously obtained from a Cre-based lineage tracing experi-
ment (Kawaguchi et al., 2002). As was previously shown,
Ptf1a-deficient MPCs contribute to the development of the DPR
and duodenum (Fig. 4A). In addition, cells forming the CBD
were also seen that expressed LacZ thereby indicating that
Ptf1a-deficient ventral MPCs do indeed become CBD progeni-
tor cells (Figs. 4B, C).
Dorsal expression of Ptf1a is independent of Pdx-1
We next examined the interdependency of Pdx-1 and Ptf1a
in embryos lacking Pdx-1 but retaining expression of Ptf1a
(Pdx-1LacZko/LacZko; Ptf1aYFP/+). Similar to prior results from
Ptf1a lineage tracing experiments in mice homozygous for a
hypomorphic Pdx-1 allele (Fujitani et al., 2006a), at E10.5 YFP
was observed only in the DPR in Pdx-1 null mice (Fig. 3I). This
finding indicates that mechanisms that establish dorsal Ptf1a
expression are independent of Pdx-1. Moreover, by immuno-
staining we observed Ptf1a in the foregut endoderm of Pdx-1
null embryos as early as E9.5 (Fig. S4). Unlike Ptf1aYFP/YFPFig. 2. YFP fluorescence in Ptf1aYFP/+ and Ptf1aYFP/YFP embryos. In Ptf1aYFP/+ emb
by whole mount fluorescence microscopy. Uniform YFP fluorescence is seen in the n
E12.5. At E13.5, YFP fluorescence is punctate which denotes acinar restriction. At E
fluorescence. In Ptf1aYFP/YFP mice, dorsal and ventral Ptf1a expression is initiated at
YFP fluorescence is lost by E12.5, but can be observed in the DPR until E13.5. Ho
bars= 50 μm unless otherwise noted. Dorsal Pancreas (DP), Ventral Pancreas (VP),mice in which YFP fluorescence is observed until E13.5,
expression of the Ptf1aYFP allele is apparent until only E12.5 in
Pdx-1 null embryos (Fig. 3J and data not shown). This result
implies that maintenance of Ptf1a expression requires Pdx-1 or
that fate allocation of Pdx-1-deficient MPCs occurs earlier than
in absence of Ptf1a because they can no longer respond to
signals that induce Ptf1a transcription, which are present until
at least E13.5.
As previously demonstrated in Pdx-1 null mice, outgrowth
of the DPR is markedly diminished (Offield et al., 1996).
Similar to Ptf1a null embryos at E12.5, we observed that
discernment of a VPR from the adjacent CBD epithelium is
questionable in Pdx-1 null embryos (Fig. 3E). The lack of
ventral YFP fluorescence indicates, as previously reported
(Fujitani et al., 2006a), not just the absence of ventral
pancreatic cells at mid-gestational stages but also supports the
idea that Pdx-1 is required for the production and/or survival
of ventral Ptf1a-expressing pancreatic MPCs (Figs. 3I, J).
Expression of Ptf1a is not reactivated at later embryonic
stages because YFP is not detected in mice lacking Pdx-1 at
E13.5 or 15.5 (data not shown), and the DPR that is derived
from Ptf1a-expressing cells undergoes only limited expansion
and branching during this time (Fujitani et al., 2006a;
Kawaguchi et al., 2002). However, as in the Ptf1a null
mice at E15.5, a VPR is not evident in the Pdx-1 null animals
(Fig. 3F) suggesting that Pdx-1, like Ptf1a, is required for
maintenance of the ventral pancreatic fate. Thus, in the
absence of Pdx-1, ventral foregut epithelial cells appear to
default to either CBD or duodenal fates although lineage
tracing in Pdx-1−/−; Ptf1aCre/+ embryos would be required to
unequivocally establish the lineages that Pdx-1 null pancreatic
MPCs adopt.
Pdx-1 is more fundamental than Ptf1a to pancreas
specification
To determine the effect of a combined inactivation of Pdx-1
and Ptf1a on pancreas development we also generated
Pdx-1LacZko/LacZko; Ptf1aYFP/YFP embryos. The phenotype of
these embryos was indistinguishable from those lacking only
Pdx-1. YFP was detected at E10.5 only dorsally, an important
result which indicates that dorsal pancreatic bud formation is
independent of Pdx-1 and Ptf1a (Fig. 3K). Also, the
developmental potency of Pdx-1; Ptf1a double null progenitor
cells is similarly limited as in Pdx-1 null mice since the
ability to respond to Ptf1a inducing signals is present until
∼E12.5 (Fig. 3L and data not shown). Analysis of Pdx-1
driven β-galactosidase expression between E12.5 and 15.5
showed that tissue morphogenesis in the double null was
identical to that of Pdx-1 null mutants (compare Figs. 3G, Hryos, YFP fluorescence can be detected in all sites of bona fide Ptf1a expression
eural tube as well as in the pancreatic buds at E10.5, which expand and fuse by
15.5, exocrine cells have proliferated which results in increased intensity of YFP
E10.5, but growth of the pancreatic buds is severely retarded by E11.5. Ventral
wever, by E15.5 YFP fluorescence is extinguished in Ptf1aYFP/YFP mice. Scale
Dorsal Pancreatic Remnant (DPR), Ventral Pancreatic Remnant (VPR).
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branched, cyst-like structure that was indistinguishable from
that observed in Pdx-1 null mice was observed (Fig. 3H).Therefore, the limited expansion and/or branching of the DPR
in Pdx-1 null embryos is not caused by the residual presence
of Ptf1a.
Fig. 4. Lineage tracing in Ptf1aCre/Cre; R26R embryos at E18.5. (A) Dorsal view of the dissected gut from a Ptf1a null embryo at E18.5. X-gal histochemistry was used
to detect cells in which the R26R allele had been recombined by the expression of Cre from the Ptf1a locus (Kawaguchi et al., 2002). This analysis indicates as
previously reported that Ptf1a-expressing cells contribute to the epithelium of the DPR as well as the duodenum in the absence of a functional Ptf1a allele. (B, C)
Sagittal views of the dissected gut shown in panel A. Ptf1a-lineage labeled cells are found in the DPR, duodenum and the CBD. This indicates that the CBD lineage is
indeed available to ventral Ptf1a null pancreatic MPCs. Duodenum (Duo), Dorsal Pancreatic Remnant (DPR), Common Bile Duct (CBD).
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and Ptf1a between E9.5 and E12.5
Although Pdx-1 and Ptf1a are expressed in pancreatic
progenitors, the spatial and temporal coincidence of their
corresponding proteins has not been examined previously (Gu
et al., 2002; Kawaguchi et al., 2002). As expected from previous
Ptf1a lineage tracing studies (Kawaguchi et al., 2002),
immunodetection of Pdx-1 and Ptf1a-driven YFP in E10.5
Ptf1aYFP/+ embryos identified their coincidence only in the
pancreatic epithelium, and not in other regions of Pdx-1
expression such as the CBD or duodenum (Fig. 5A). Since
YFP perdurance in Ptf1a-negative cells could be misconstrued
as indicating Ptf1a expression [due to the slightly longer half-
life of YFP than Ptf1a, as shown in Fig. S1] we examined Ptf1a
protein expression directly using an antibody that produces no
signal on Ptf1a−/−mutant tissue (Figs. S2A, B). Ptf1a was found
to coincide with Pdx-1 in the vast majority of pancreatic
epithelial cells from E9.5 to 10.5 (Figs. 5B, S2C, S3A–D).
Furthermore, at E11.5 Pdx-1 and Ptf1a still coincide in almost all
pancreatic epithelial cells (data not shown). To our knowledgeFig. 3. Pancreas morphogenesis in Pdx-1 null, Ptf1a null, and Pdx-1, Ptf1a double nu
Pdx-1LacZko allele in Pdx-1 null (Pdx-1LacZko/LacZko; Ptf1aYFP/+), Ptf1a null (Pdx-1LacZk
embryos at E12.5 and E15.5. A) In Pdx-1LacZko/+; Ptf1aYFP/+ E12.5 embryos, the dors
from the CBD epithelium and the two lobes have fused near the duodenum at their pro
branching and lobulation indicates acinar development. X-gal staining also denotes
bladder. (C) In Ptf1a null embryos at E12.5, the epithelium of the DPR is growth defi
embryos at E15.5, LacZ expression is observed in the DPR which is minimally branc
indicates assimilation of ventral pancreatic MPCs into the CBD and/or duodenum epit
Ptf1a null embryos at the same stage while they display a similar structure resemblin
Ptf1aYFP/+ embryos undergoes limited branching and X-gal staining is more intense in
although no gross abnormalities are observed. As in Ptf1a null mice, there appears to
ventral pancreatic cells have contributed to the epithelium of the CBD and/or duodenu
identical to Pdx-1 null embryos. (I–L)Wholemount fluorescencemicroscopy of YFP (
(I, J) In Pdx-1 null embryos, YFP can be observed in the DPR fromE10.5–12.5. YFP is
and thatPtf1a expressionmay be dependent on Pdx-1 after E12.5. (K, L) YFP fluoresc
dorsal expression of Ptf1a or epithelial budding. Scale bars=50 μm. Duodenum (Duo)
Cystic Duct (CD), Gall Bladder (GB), Dorsal Pancreatic Remnant (DPR), Ventral Pathis is the first report of the concurrent expression of both Pdx-1
and Ptf1a at the protein level in the pre-pancreatic endoderm at
E9.5 as well as their persistence in pancreatic MPCs past E10.5.
By E12.5, Ptf1a has begun to compartmentalize to the distal tips
of the pancreatic epithelium (Figs. S1, S2A), a MPC pool that is
also Pdx-1-positive (Fig. S2A) (Zhou et al., 2007). Thus, a
hallmark of pancreatic MPCs appears to be the coincidence of
Pdx-1 and Ptf1a protein from E9.5 to around E12.5. This finding
is consistent with a recent report that suggests this stage of
embryonic development is a crucial period during which a fixed
number of pancreatic progenitors is specified since eliminating
cells from this progenitor pool reduces the final size of the organ
(Stanger et al., 2007). However, by about E13 Ptf1a-expressing
cells appear to become unipotent and, thereafter, only give rise
to acinar cells (Zhou et al., 2007).
Pdx-1, but not Ptf1a, is required to sustain pancreatic Ngn3
expression past E9.5
Previous single-cell PCR analysis of early pancreas bud cells
at E10.5 suggests that Ngn3 is expressed in a subset of cells thatll embryos. (A–H) Histological analysis of β-galactosidase expression from the
o/+; Ptf1aYFP/YFP), and Pdx-1, Ptf1a double null (Pdx-1LacZko/LacZko; Ptf1aYFP/YFP)
al pancreas is associated with the duodenum, the ventral pancreas is evaginating
ximal ends. (B) At E15.5 in Ptf1aYFP/+; Pdx-1LacZko/+ embryos, normal epithelial
Pdx-1 expression in the CBD, extrahepatic biliary ducts, cystic duct, and gall
cient and does not branch while the VPR is barely discernable. (D) In Ptf1a null
hed and extends from the duodenum towards the spleen. The absence of a VPR
helium. (E) Pdx-1 null embryos at E12.5 have a considerably smaller DPR than in
g a VPR contiguous with the CBD. (F) By E15.5 the DPR of Pdx-1LacZko/LacZko;
the gall bladder and cystic duct, due to homozygosity of the Pdx-1LacZko alleles,
be no VPR associated with the CBD in Pdx-1 null mice at E15.5 which suggests
m. (G, H) The morphological phenotype of Pdx-1, Ptf1a double null embryos is
Ptf1aYFP) in Pdx-1 null and Pdx-1, Ptf1a double null embryos at E10.5 and E12.5.
not detectable at E13.5which indicates a loss of dorsal pancreatic progenitor cells
ence in double null embryos indicates that neither Pdx-1 nor Ptf1a is necessary for
, Stomach (Sto), Extrahepatic Biliary Ducts (EHBD), Common Bile Duct (CBD),
ncreatic Remnant (VPR).
Fig. 5. Developmental compartmentalization of Pdx-1, Ptf1a, and Ngn3. (A) Immunofluorescent analysis of Pdx-1 and Ptf1aYFP expression at E10.5 indicates
their coincidence throughout the dorsal and ventral pancreatic epithelium with the exception of the first wave endocrine cells. The duodenum and CBD are only
Pdx-1-positive and do not express Ptf1a. (B) Confocal immunofluorescence analysis for Pdx-1, Ptf1a, and Ngn3 in pancreatic progenitor cells of the dorsal
pancreatic bud at E10.5. Ptf1a, Pdx-1, and Ngn3 coincide in scattered cells throughout the pancreatic epithelium at E10.5 (*) although Ptf1a staining in these cells is
relatively weak compared to those that do not express Ngn3. Some Ngn3-positive cells are Ptf1a-negative (†), but all Ptf1a-positive and Ngn3-positive cells express
Pdx-1. (C) Compartmentalization of Ptf1aYFP and Ngn3 expression. By E13.5 and thereafter, Ngn3-positive cells reside in the Pdx-1-positive ductal cords of the
pancreas, but do not coincide with YFP which is restricted to pro-acinar structures. Thus, early Ngn3-positive cells express Ptf1a while subsequent generations do
not. D) Ptf1a is not necessary for Ngn3 expression. Ngn3-positive cells are found throughout the DPR of Ptf1aYFP/YFP embryos at E11.5 along with Pdx-1 and YFP.
Also, YFP-positive cells are observed in a columnar epithelium near the site where the ventral pancreas arises which illustrates a lack of coalescence of Ptf1a-
expressing cells into a distinct epithelial bud. This suggests that these cells are already specified to a duodenal and/or CBD fate. Dorsal Pancreas (DP), Ventral
Pancreas (VP), Dorsal Pancreatic Remnant (DPR), Ventral Pancreatic Remnant (VPR), Common bile duct (CBD), Duodenum (Duo), Red blood cell (RBC).
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this reason, we sought to determine how the individual or
combined loss of Pdx-1 and Ptf1a affects Ngn3 expression and
endocrine cell specification. By immunostaining, Ngn3-posi-
tive cells were detected in the pre-pancreatic endoderm at E9.5,
although they only appeared to express Pdx-1 and not Ptf1a
(Figs. S3A–D). However, cells positive for Pdx-1, Ptf1a, and
Ngn3 protein were observed to be dispersed throughout the
pancreatic epithelium of E10.5 wild type embryos (Figs. 5B,
S2C). The Ptf1a signal, while present above background, was
weaker in Ngn3-positive cells and some Ngn3-positive cells did
not stain for Ptf1a. Thus, as cells commit to Ngn3 expression,
there appears to be an associated down-regulation of Ptf1a. At
later embryonic stages (E13.5 and E15.5), Ptf1a no longer
coincides with Ngn3 and instead is restricted to acinar cells
(Fig. 5C).
As would be predicted by the presence of endocrine cells in
Ptf1a null mice, Ngn3 is present in Ptf1aYFP/YFP embryos at
E11.5 (Fig. 5D). In contrast, although insulin- and glucagon-
expressing cells were present in Pdx-1 null (Pdx-1LacZko/LacZko;
Ptf1aYFP/+) and Pdx-1; Ptf1a double null (Pdx-1LacZko/LacZko;
Ptf1aYFP/YFP) embryos obtained between E10.5 and 12.5 (Figs.
6B, C and S3I, J), detectable levels of Ngn3 protein were not
observed anywhere within the pancreatic epithelium (Figs. 6E,F and S3I,J). However, Ngn3-positive cells were present in the
pre-pancreatic endoderm at E9.5 in the absence of either Pdx-1
or both Pdx-1 and Ptf1a (Figs. S3F, G). These results indicate
that both first-wave endocrine cells and their progenitors can be
specified independently of both Pdx-1 and Ptf1a. In addition,
given that Ngn3-positive endocrine progenitors were not
observed at E10.5 in Pdx-1 null embryos, these findings
suggest that the Ngn3-positive cells present at E9.5 are rapidly
depleted as they and/or their progeny give rise to the first wave
endocrine cells.
Ptf1a is not required for β-cell maturation
Finally, we sought to determine whether Ptf1a is necessary
for β-cell maturation by examining expression of both insulin
and MafA in Ptf1a null mice. MafA was examined since it is
currently considered to represent a marker of the terminal stages
of normal beta cell differentiation (Matsuoka et al., 2004). In
contrast to previous reports (Kawaguchi et al., 2002; Krapp et
al., 1998), splenic endocrine cells were not observed in Ptf1a
null mice by immunofluorescence. Thus, to identify more
readily the presence of insulin-producing cells we intercrossed
mice bearing the Ptf1aYFP allele with MIP:GFP transgenic
animals (Hara et al., 2003). At E18.5, Ptf1aYFP/YFP; MIP:GFP
Fig. 6. Early endocrine cells develop independently of Pdx-1 and Ptf1a. Immunofluorescence analysis for insulin, glucagon and Pdx-1. (A) First wave insulin- and
glucagon-expressing cells are associated with the pancreatic epithelium of wild type mice at E12.5. These endocrine cells are also present in the DPR of Pdx-1 null (B),
and Pdx-1; Ptf1a double null (C) mice which indicates that neither transcription factor is necessary for their formation. (D) Ngn3 is observed in the dorsal pancreas of
wild type embryos at E12.5 but not in Pdx-1 null (E) or Pdx-1; Ptf1a double null (F) embryos, which suggests that Pdx-1 is required to sustain the specification of
pancreatic Ngn3–expressing endocrine progenitors from an MPC pool. Scale bars=25 μm.
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positive cells were sparsely distributed in the DPR but not in the
spleen (Fig. 7C). β-cell mass appeared to be greatly reduced in
Ptf1aYFP/YFP; MIP:GFP embryos compared to MIP:GFP mice
(Figs. 7A and C). In Ptf1a null mice at E18.5, 83.0±2.0% of
insulin producing cells are MafA-positive and appear as single
cells and in small clusters associated with the cystic, ductal
epithelium of the DPR (Fig. 7D). MafA/insulin co-positive cells
had more intense Pdx-1 staining than the MafA-negative
insulin-expressing cells (data not shown). In wild type mice,
insulin-producing cells were clustered in larger islet-like
structures and 91.0±2.0% were positive for MafA (Fig. 7B).
While the reduced proportion of MafA-expressing insulin-
positive cells in Ptf1a null tissue was statistically significant
(Pb0.01), the majority of the insulin-producing cells were
MafA-positive thereby suggesting that Ptf1a function is not
required for β-cell maturation.
Discussion
Derivation of a Ptf1aLCA allele and insertion of YFP by RMCE
Mice carrying a Ptf1aYFP allele were generated by a
combined gene targeting and RMCE strategy in order to
facilitate detection and analysis of cells expressing Ptf1a. The
Ptf1aYFP allele closely mimicked expression of the endoge-
neous allele except for a small increase in YFP perdurance
compared to Ptf1a in pancreatic tissue. However, the extended
detectability of YFP may, in fact, be a useful trait in certain
circumstances as it is able to identify cells that have recently
terminated Ptf1a transcription. In addition, ES cells carrying the
Ptf1aLCA allele will have continuing utility since they enableother mutations and reporters to be rapidly inserted into the
Ptf1a gene locus by RMCE.
Pdx-1-positive foregut endodermal cells respond to Ptf1a
inducing signals from E10.5 to E13.5
Previous studies using Flk1 null embryos have implicated
endothelial cells in the activation of Ptf1a gene transcription in
the dorsal, but not the ventral pancreatic bud. This is consistent
with the observation that normal aortic endothelium, when co-
cultured with Flk1 null dorsal foregut endoderm, restores
Ptf1a expression (Yoshitomi and Zaret, 2004). Although the
factor(s) that induce Ptf1a expression remain unidentified, our
studies of Ptf1aYFP/YFP embryos allow us to propose that the
signaling mechanisms that initiate expression of Ptf1a remain
active in the dorsal and ventral pre-pancreatic endodermal
regions until ∼E13.5 and ∼E11.5, respectively. The loss of
Ptf1aYFP expression after this time is consistent with the
pancreatic MPC population having either undergone a change
in fate to become some other tissue (e.g., duodenum, CBD) or
having entered into a subsequent phase of pancreatic lineage
diversification and differentiation. In other words, we propose
that posterior foregut endoderm cells that express Pdx-1 have a
limited window of competence in which to respond to pro-
pancreatic signals, and that this interval is shorter in ventral
than dorsal foregut endoderm. We consider it likely that the
DPR in Ptf1a null embryos is derived from pancreatic MPCs
that escape signaling mechanisms which drive alternate fate
specifications. Indeed, given that Stanger et al. have shown
that depletion of pancreatic MPCs reduces final organ size
(Stanger et al., 2007), we suggest that the reduced numbers of
pancreatic MPCs contributing to the DPR in Ptf1a null
Fig. 7. MafA is expressed in insulin-producing cells of Ptf1a null embryos. (A) Whole mount fluorescence microscopy of gut sections from E18.5MIP:GFP embryos
indicates β-cell specific GFP fluorescence. (B) Confocal immunofluorescence analysis of insulin and MafA in wild type embryos at E18.5. DRAQ5™ was used as a
nuclear counterstain. 91.0±2.0% of the insulin-producing cells express MafA in wild type mice indicating that they are mature β-cells. (C) Whole mount fluorescence
of theMIP:GFP transgene in Ptf1aYFP/YFP embryos at E18.5 allows direct observation of insulin-producing cells since YFP is not expressed past ∼E13.5 in Ptf1a null
mice. In contrast to previous reports, we do not observe pancreatic endocrine cells in the spleen. Rather they are localized to the DPR. (D) Confocal immuno-
fluorescence analysis of insulin and MafA in Ptf1aYFP/YFP embryos at E18.5. DRAQ5™ was used as a nuclear counterstain. 83.0±2.0% of the insulin-producing cells
in Ptf1a null embryos express MafA which indicates that the majority also possess properties of mature β-cells. Therefore Ptf1a does not directly contribute to
endocrine cell maturation. The ∼8.5% decrease of MafA expression in insulin-producing cells is statistically significant (Pb0.01), however the apparent reduction in
β-cell mass is the more dominant phenotype (compare A and C).
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thereby accounting for its abrogated expansion. However,
further studies will be necessary to determine whether
decreased proliferation and/or increased apoptosis of pancrea-
tic MPCs may also contribute to the diminished size of the
DPR in Ptf1a null embryos.
Ptf1a and Pdx-1 are independently required for specification of
the ventral pancreas
In E15.5 Ptf1a null embryos there is no VPR visible
whereas a DPR is clearly evident. Since, normally, the ventral
pancreas buds off from and remains associated with the CBD
we hypothesized that the absence of Ptf1a leads to adoption
of CBD fates by ventral cells that should have become
pancreas. This led us to further examine the results of a
previous lineage tracing experiment (Kawaguchi et al., 2002)
and to find that ventral pancreas MPCs that lack Ptf1a do
indeed contribute to the development of the CBD, as well as
the duodenum. This conclusion is consistent with recent
studies establishing a common origin for cells of the ventral
pancreas and CBD (Fukuda et al., 2006a; Sumazaki et al.,
2004).
In Pdx-1 null embryos at E15.5 the DPR is much smaller
(Offield et al., 1996) than in Ptf1a null mice at the same age.
Additionally, these embryos lack a VPR. As is the case for the
Ptf1a null animals it seems that ventral “prospective pancreatic”
endodermal cells appear to integrate into the CBD epithelium
and become committed to this alternate developmental program
at a very early stage. In fact, the specification, production, and/or survival of ventral MPCs appears to be altogether deficient in
Pdx-1 null embryos since we never observed ventral Ptf1aYFP
expression beyond E10.5.
Neither Pdx-1 nor Ptf1a is required to initiate a dorsal
pancreatic program
Recently, Ptf1a lineage tracing in Pdx-1 hypomorphic
embryos was used to show that Ptf1a transcription requires
higher Pdx-1 expression levels in ventral foregut endoderm
compared to dorsal foregut endoderm (Fujitani et al., 2006a).
However, here we report for the first time that dorsal Ptf1a
expression is independent of Pdx-1 since Ptf1aYFP is
regionally activated in the absence of Pdx-1 between E10.5
and 12.5. Moreover, in Pdx-1−/−; Ptf1aYFP/+ embryos, YFP
fluorescence is lost after E12.5, a full day earlier than in Ptf1a
null embryos. Because the signals inducing Ptf1aYFP expres-
sion are present until at least E13.5 (as described above)
pancreatic MPCs may undergo lineage diversification more
rapidly in the absence of Pdx-1 than of Ptf1a. Alternatively,
the loss of Ptf1aYFP expression could also reflect either the
decreased proliferation and/or increased apoptosis of Pdx-1
null pancreatic MPCs. In any case, the earlier depletion of
pancreatic MPCs in Pdx-1 null embryos seems likely to
account for the smaller size of the DPR compared to Ptf1a
null mice.
The analysis of Pdx-1; Ptf1a double homozygous null
embryos showed that Ptf1a is initially expressed in the dorsal,
but not ventral, pancreatic remnant, which undergoes abrogated
expansion and branching in a phenotype identical to that of Pdx-
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null DPR does not involve Ptf1a, and strongly supports the idea
that Pdx-1 is necessary to render the posterior foregut endoderm
competent to respond to Ptf1a. Furthermore, the highly
localized expression of Ptf1a in double null mutant embryos
indicates that there must be an underlying parallel molecular
genetic program leading to the specification and outgrowth of
the dorsal pancreatic bud.
The co-expression of Pdx-1 and Ptf1a identify pancreatic
MPCs
Indirect lineage-labeling methods have shown that both Ptf1a
and Pdx-1 are expressed in pancreatic MPC-type cells (Gu et al.,
2002; Kawaguchi et al., 2002). Here, we show that both factors
are co-expressed in most, if not all, pancreatic MPCs between
E9.5 and 12.5. Given that Ptf1a can induce ectopic pancreas
formation from the CBD epithelium in Hes1 null mice (Fukuda
et al., 2006a) our observations further support the notion that
Pdx-1/Ptf1a co-production is obligatory for specification of
pancreatic MPCs. Sox9, which has also recently been shown to
play an important role in pancreatic MPCs as evidenced by
pancreatic hypoplasia in the absence of this transcription factor,
may complement the function of both Pdx-1 and Ptf1a by also
promoting the maintenance of multipotency, survival and/or
proliferation of pancreatic MPCs (Seymour et al., 2007).
As pancreatic development proceeds, Ptf1a-expression
becomes compartmentalized to the periphery of the pancreas
epithelium between E11.5 and 12.5. The recent work of Zhou et
al., which complements our findings, also concluded that cells in
the distal tips of the pancreas epithelium that express Pdx-1,
Ptf1a, cMyc and Cpa1 are tripotent pancreatic MPCs with the
ability to differentiate into endocrine, acinar and duct cells (Zhou
et al., 2007). At approximately E13, Ptf1a-positive cells appear
to switch to a pro-acinar transit amplifying pool (Zhou et al.,
2007) and, shortly thereafter, acinar markers begin to be
expressed (Chiang and Melton, 2003; Guz et al., 1995). Our
findings are also consistent with those of Stanger et al. (2007)
andMasui et al. (2007). Indeed, the latter study has indicated that
a change in the subunit composition of the trimeric Ptf1 complex
occurs at this time.
Although the early pancreatic MPC pool appears homo-
geneous with respect to the coincidence of both Pdx-1 and
Ptf1a, these cells are likely to be heterogeneous with respect to
the expression of other genes. At least six types of progenitor
cells have previously been identified in the E10.5 pancreas
epithelium based on the expression combinations of Pdx-1,
Nkx2.2, Nkx6.1, Ptf1a, Ngn3, Pax4, Pax6, Isl1, NeuroD, Gcg,
Ins, Sst, and PP as determined by single-cell RT-PCR analysis
(Chiang and Melton, 2003). Indeed, one class of cells that was
identified express Ptf1a, Pdx-1, and Ngn3. Our results confirm
the coincidence of Pdx-1, Ptf1a, and Ngn3 in a subset of
pancreatic epithelial cells from E10.5–11.5. However, the
precise identification and functional characterization of all
pancreatic MPC subtypes will be necessary for understanding
pancreas development and how lineage specifications occur in a
spatiotemporally regulated manner.Endocrine cell differentiation and the role of Ngn3
While the ontogeny, fate, and function of endocrine cells
formed before E13.5 remains unclear, Ngn3 is required for
their formation (Gradwohl et al., 2000). In this study we found
pancreatic insulin- and glucagon-producing cells in Pdx-1 null
and Pdx-1; Ptf1a double null embryos from E10.5–12.5, which
do not express detectable levels of Ngn3. However, Ngn3-
positive cells were found in the pre-pancreatic endoderm at
E9.5 in the absence of Pdx-1. This suggests that Pdx-1 is
required for the sustained derivation of endocrine progenitor
cells from a pancreatic MPC pool past E9.5. Given this, it is
important to understand how Pdx-1 mediates the specification
of pancreatic endocrine progenitors in vivo to increase the
efficiency of deriving Ngn3-expressing cells from human ES
cells in vitro.
In contrast to Pdx-1 deficiency, Ptf1a null pancreatic tissue
contained close to wild-type numbers of readily detectable
Ngn3-producing cells at E11.5, a finding that agrees with the
study of Flk-1−/− embryos where dorsal pancreatic Ngn3
transcription was activated in the absence of Ptf1a induction
(Yoshitomi and Zaret, 2004). Although one previous study of
Ptf1a null mice reported the identification of endocrine cells
in close proximity to the pancreatic region until ∼E17.5, at
which time they were inferred to migrate into the spleen (Krapp
et al., 1998), we were unable to identify such splenic endocrine
cells, even in Ptf1aYFP/YFP embryos that were analyzed just
prior to parturition. Instead, by using a MIP:GFP transgene to
facilitate the identification of pancreatic β-cells, we found these
cells scattered along the DPR. While Kawaguchi et al. also
reported finding splenic endocrine cells in Ptf1a null embryos
(Kawaguchi et al., 2002), review of the primary data indicates
that the former conclusion can no longer be supported. The
faint immunostaining observed previously by Kawaguchi et
al. appears in retrospect to have been non-specific since, in
the current study, GFP-positive cells were not observed in the
spleens of Ptf1aYFP/YFP; MIP:GFP embryos at E18.5.
The insulin-producing cells found in the Ptf1a null mice were
found to express MafA, a marker of late-stage β-cell maturation
(Matsuoka et al., 2004). While the physiological function of
these β-cells could not be tested directly because Ptf1a null
animals die perinatally, this result supports the previously
proposed hypothesis that the normal pancreas has both Ptf1a-
dependent and Ptf1a-independent pancreatic endocrine
lineages, wherein only 95% of adult duct and insulin cell
types, and 75% of glucagon cells, were labeled in Ptf1a lineage-
tracing studies (Kawaguchi et al., 2002). The expression of
MafA in the insulin-producing cells of Ptf1a null mice further
supports the notion for there being more than one natural
pathway for generating mature β-cells in vivo. A corollary of
these findings is that these different developmental programs
might have specific properties that make them more or less
amenable to large-scale recapitulation in vitro. It therefore
remains possible that, although Ptf1a is not absolutely required
for the generation of mature β-cells in vivo, the induction of a
Ptf1a-expressing MPC state may be necessary for the efficient
derivation of β-cells.
86 J.S. Burlison et al. / Developmental Biology 316 (2008) 74–86Finally, our results may have direct bearing on the
derivation of insulin-expressing cells from human ES cells
(D'Amour et al., 2006). If pancreatic MPCs have a very
restricted proliferative capacity, as several studies now suggest,
greater knowledge of the factors that determine both the
specification and maintenance of this important pool of cells
may in time enable the development of novel strategies for
either regenerating specific pancreatic lineages, such as β-
cells, in vivo, or generating such cells ex vivo through the
directed differentiation of human ES cells, or other such
pluripotent cells.
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